• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
37.3
71.68
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

n2n technologies ltd
Manaksia consolidated net profit rises 2.35% in the March 2026 quarter
Jun 01,2026
Net profit of Manaksia rose 2.35% to Rs 11.78 crore in the quarter ended March 2026 as against Rs 11.51 crore during the previous quarter ended March 2025. Sales declined 11.87% to Rs 236.68 crore in the quarter ended March 2026 as against Rs 268.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 6.50% to Rs 52.34 crore in the year ended March 2026 as against Rs 55.98 crore during the previous year ended March 2025. Sales rose 7.26% to Rs 784.09 crore in the year ended March 2026 as against Rs 731.05 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales236.68268.56 -12 784.09731.05 7
OPM %7.385.44 -5.267.41 -
PBDT14.1121.48 -34 76.1796.82 -21
PBT12.8720.08 -36 70.6591.30 -23
NP11.7811.51 2 52.3455.98 -7